276 related articles for article (PubMed ID: 9243100)
1. Altered immunoreactivity of islet amyloid polypeptide (IAPP) may reflect major modifications of the IAPP molecule in amyloidogenesis.
Ma Z; Westermark GT; Li ZC; Engström U; Westermark P
Diabetologia; 1997 Jul; 40(7):793-801. PubMed ID: 9243100
[TBL] [Abstract][Full Text] [Related]
2. Islet pathology of non-insulin-dependent diabetes mellitus (NIDDM).
Westermark P
Diabet Med; 1996 Sep; 13(9 Suppl 6):S46-8. PubMed ID: 8894481
[TBL] [Abstract][Full Text] [Related]
3. Amyloidogenicity and cytotoxicity of islet amyloid polypeptide.
Kapurniotu A
Biopolymers; 2001; 60(6):438-59. PubMed ID: 12209476
[TBL] [Abstract][Full Text] [Related]
4. Islet amyloid polypeptide: mechanisms of amyloidogenesis in the pancreatic islets and potential roles in diabetes mellitus.
Johnson KH; O'Brien TD; Betsholtz C; Westermark P
Lab Invest; 1992 May; 66(5):522-35. PubMed ID: 1573849
[TBL] [Abstract][Full Text] [Related]
5. Amyloid in human islets of Langerhans: immunologic evidence that islet amyloid polypeptide is modified in amyloidogenesis.
Ma Z; Westermark P; Westermark GT
Pancreas; 2000 Aug; 21(2):212-8. PubMed ID: 10975716
[TBL] [Abstract][Full Text] [Related]
6. Immunolocalization of islet amyloid polypeptide (IAPP) in pancreatic beta cells by means of peroxidase-antiperoxidase (PAP) and protein A-gold techniques.
Johnson KH; O'Brien TD; Hayden DW; Jordan K; Ghobrial HK; Mahoney WC; Westermark P
Am J Pathol; 1988 Jan; 130(1):1-8. PubMed ID: 3276206
[TBL] [Abstract][Full Text] [Related]
7. [Role of IAPP in the pathogenesis and development of NIDDM].
Sanke T; Nishi M; Nanjo K
Nihon Rinsho; 1994 Oct; 52(10):2737-45. PubMed ID: 7983807
[TBL] [Abstract][Full Text] [Related]
8. Islet amyloid, islet-amyloid polypeptide, and diabetes mellitus.
Johnson KH; O'Brien TD; Betsholtz C; Westermark P
N Engl J Med; 1989 Aug; 321(8):513-8. PubMed ID: 2668761
[TBL] [Abstract][Full Text] [Related]
9. [Construction of transgenic mouse system expressing human islet amyloid polypeptide (IAPP)/amylin].
Yagui K; Kanatsuka A; Makino H
Nihon Rinsho; 1994 Oct; 52(10):2746-50. PubMed ID: 7983808
[TBL] [Abstract][Full Text] [Related]
10. Islet amyloid polypeptide: a review of its biology and potential roles in the pathogenesis of diabetes mellitus.
O'Brien TD; Butler PC; Westermark P; Johnson KH
Vet Pathol; 1993 Jul; 30(4):317-32. PubMed ID: 8212454
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic beta-cell granule peptides form heteromolecular complexes which inhibit islet amyloid polypeptide fibril formation.
Jaikaran ET; Nilsson MR; Clark A
Biochem J; 2004 Feb; 377(Pt 3):709-16. PubMed ID: 14565847
[TBL] [Abstract][Full Text] [Related]
12. Islet amyloid polypeptide in proliferating pancreatic B cells during development, hyperplasia, and neoplasia in humans and mice.
Rindi G; Terenghi G; Westermark G; Westermark P; Moscoso G; Polak JM
Am J Pathol; 1991 Jun; 138(6):1321-34. PubMed ID: 1647136
[TBL] [Abstract][Full Text] [Related]
13. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus.
Westermark P; Andersson A; Westermark GT
Physiol Rev; 2011 Jul; 91(3):795-826. PubMed ID: 21742788
[TBL] [Abstract][Full Text] [Related]
14. Islet amyloid polypeptide and its N-terminal and C-terminal flanking peptides' immunoreactivity in islet amyloid of diabetic patients.
Kanatsuka A; Makino H; Yagui K; Huang CI; Taira M; Mikata A; Yoshida S
Diabetes Res Clin Pract; 1994 Dec; 26(2):101-7. PubMed ID: 7535678
[TBL] [Abstract][Full Text] [Related]
15. Ferret islet amyloid polypeptide (IAPP): characterization of in vitro and in vivo amyloidogenicity.
Paulsson JF; Benoit-Biancamano MO; Schäffer L; Dahl K
Amyloid; 2011 Dec; 18(4):222-8. PubMed ID: 22047620
[TBL] [Abstract][Full Text] [Related]
16. Human islet amyloid polypeptide accumulates at similar sites in islets of transgenic mice and humans.
de Koning EJ; Höppener JW; Verbeek JS; Oosterwijk C; van Hulst KL; Baker CA; Lips CJ; Morris JF; Clark A
Diabetes; 1994 May; 43(5):640-4. PubMed ID: 8168639
[TBL] [Abstract][Full Text] [Related]
17. Extensive islet amyloid formation is induced by development of Type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model.
Höppener JW; Oosterwijk C; Nieuwenhuis MG; Posthuma G; Thijssen JH; Vroom TM; Ahrén B; Lips CJ
Diabetologia; 1999 Apr; 42(4):427-34. PubMed ID: 10230646
[TBL] [Abstract][Full Text] [Related]
18. Islet amyloid polypeptide (IAPP) and pancreatic islet amyloid deposition in diabetic and non-diabetic patients.
Narita R; Toshimori H; Nakazato M; Kuribayashi T; Toshimori T; Kawabata K; Takahashi K; Masukura S
Diabetes Res Clin Pract; 1992 Jan; 15(1):3-14. PubMed ID: 1541232
[TBL] [Abstract][Full Text] [Related]
19. An in vitro model of early islet amyloid polypeptide (IAPP) fibrillogenesis using human IAPP-transgenic mouse islets.
Henson MS; Buman BL; Jordan K; Rahrmann EP; Hardy RM; Johnson KH; O'Brien TD
Amyloid; 2006 Dec; 13(4):250-9. PubMed ID: 17107885
[TBL] [Abstract][Full Text] [Related]
20. Islet amyloid polypeptide-like immunoreactivity in the islet B cells of type 2 (non-insulin-dependent) diabetic and non-diabetic individuals.
Westermark P; Wilander E; Westermark GT; Johnson KH
Diabetologia; 1987 Nov; 30(11):887-92. PubMed ID: 3328723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
